Market open
Mangoceuticals/$MGRX
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Mangoceuticals
Mangoceuticals Inc focuses on developing, marketing, and selling a variety of men's wellness products and services through a telemedicine platform. The company's platform provides access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations, including Mango ED products.
Ticker
$MGRX
Sector
Trading on
Industry
Consumer Staples Distribution & Retail
Headquarters
Employees
3
ISIN
US56270V2051
Website
Mangoceuticals Metrics
BasicAdvanced
$10M
-
-$4.84
1.51
-
Price and volume
Market cap
$10M
Beta
1.51
52-week high
$5.33
52-week low
$1.49
Average daily volume
327K
Financial strength
Current ratio
0.053
Quick ratio
0.041
Total debt to equity
1.541
Interest coverage (TTM)
-601.44%
Management effectiveness
Return on assets (TTM)
-62.72%
Return on equity (TTM)
-118.31%
Valuation
Price to revenue (TTM)
5.27
Price to book
0.38
Price to tangible book (TTM)
-4.14
Price to free cash flow (TTM)
-0.667
Growth
Revenue change (TTM)
-15.81%
Earnings per share change (TTM)
-43.56%
Mangoceuticals News
AllArticlesVideos
ArcStone Securities and Investments Corp. Publishes Industry Report on The Rapid Expansion of The Oral Stimulant Pouch Market
Newsfile Corp·2 weeks ago
CORRECTION FROM SOURCE: ArcStone Securities and Investments Corp. Serves as Exclusive Financial Advisor to Mangoceuticals Inc. (MGRX) on its Transformative Acquisition of IP Assets of Smokeless Technology Corp. Marking its Entry into the High Growth Oral Stimulant Pouch Sector
Newsfile Corp·3 weeks ago
ArcStone Securities and Investments Corp. Serves as Exclusive Financial Advisor to Mangoceuticals Inc. (MGRX) on its Transformative Acquisition of Smokeless Technology Corp. Marking its Entry into the High Growth Oral Stimulant Pouch Sector
Newsfile Corp·3 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Mangoceuticals stock?
Mangoceuticals (MGRX) has a market cap of $10M as of May 14, 2025.
What is the P/E ratio for Mangoceuticals stock?
The price to earnings (P/E) ratio for Mangoceuticals (MGRX) stock is 0 as of May 14, 2025.
Does Mangoceuticals stock pay dividends?
No, Mangoceuticals (MGRX) stock does not pay dividends to its shareholders as of May 14, 2025.
When is the next Mangoceuticals dividend payment date?
Mangoceuticals (MGRX) stock does not pay dividends to its shareholders.
What is the beta indicator for Mangoceuticals?
Mangoceuticals (MGRX) has a beta rating of 1.51. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.